SevenBridge Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

SevenBridge Financial Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-300	Closed	-$4K	–	224
2019 Q2	$4K	Hold	300	–	–	﹤0.01%	536
2019 Q1	$5K	Hold	300	–	–	﹤0.01%	481
2018 Q4	$5K	Hold	300	–	–	﹤0.01%	440
2018 Q3	$4K	Hold	300	–	–	﹤0.01%	501
2018 Q2	$7K	Buy	+300	New	+$7.38K	﹤0.01%	459

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SevenBridge Financial Group's COLL Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Collegium Pharmaceutical (COLL) in Q3 2019, closing a stake of 300 shares — an estimated $4K sold.

SevenBridge Financial Group first reported a position in COLL in Q2 2018 and held it in 5 quarters. The position peaked at $7K in Q2 2018. 117 funds tracked by Wall St. Rank hold COLL as of Q3 2019.

SevenBridge Financial Group reported no remaining Collegium Pharmaceutical position as of Q3 2019 after selling out during the quarter.
SevenBridge Financial Group sold 300 Collegium Pharmaceutical shares in Q3 2019, an estimated $4K.
SevenBridge Financial Group first reported a position in Collegium Pharmaceutical in Q2 2018 and held it in 5 quarters.
SevenBridge Financial Group's Collegium Pharmaceutical position peaked at $7K in Q2 2018.
117 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.